Bionano Genomics Enters Into Debt and Equity Financing Agreements Totaling $41.5 Million in Commitments – Business Wire

Bionano Genomics Enters Into Debt and Equity Financing Agreements Totaling $41.5 Million in Commitments Business Wire

Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and ul.